Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-25-064180
Filing Date
2025-03-26
Accepted
2025-03-26 17:15:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A d935461ddefa14a.htm DEFA14A 26201
  Complete submission text file 0001193125-25-064180.txt   27231
Mailing Address 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110
Business Address 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110 857-204-8109
Atea Pharmaceuticals, Inc. (Filer) CIK: 0001593899 (see all company filings)

EIN.: 460574869 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39661 | Film No.: 25774298
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)